GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » Cyclically Adjusted PS Ratio

Quest Diagnostics (FRA:QDI) Cyclically Adjusted PS Ratio : 2.07 (As of Jun. 01, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Quest Diagnostics's current share price is €150.95. Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €72.79. Quest Diagnostics's Cyclically Adjusted PS Ratio for today is 2.07.

The historical rank and industry rank for Quest Diagnostics's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:QDI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.36   Med: 1.98   Max: 2.78
Current: 2.16

During the past years, Quest Diagnostics's highest Cyclically Adjusted PS Ratio was 2.78. The lowest was 1.36. And the median was 1.98.

FRA:QDI's Cyclically Adjusted PS Ratio is ranked worse than
52.27% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.06 vs FRA:QDI: 2.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Quest Diagnostics's adjusted revenue per share data for the three months ended in Mar. 2025 was €21.709. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €72.79 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quest Diagnostics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Quest Diagnostics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Cyclically Adjusted PS Ratio Chart

Quest Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.11 2.73 2.24 1.85 1.92

Quest Diagnostics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.75 1.78 1.99 1.92 2.11

Competitive Comparison of Quest Diagnostics's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted PS Ratio falls into.


;
;

Quest Diagnostics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Quest Diagnostics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=150.95/72.79
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Quest Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=21.709/134.9266*134.9266
=21.709

Current CPI (Mar. 2025) = 134.9266.

Quest Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 11.829 100.684 15.852
201509 11.552 100.392 15.526
201512 11.706 99.792 15.827
201603 11.618 100.470 15.602
201606 11.946 101.688 15.851
201609 11.828 101.861 15.668
201612 10.639 101.863 14.092
201703 12.049 102.862 15.805
201706 11.850 103.349 15.471
201709 11.123 104.136 14.412
201712 11.257 104.011 14.603
201803 10.992 105.290 14.086
201806 11.818 106.317 14.998
201809 11.647 106.507 14.755
201812 11.629 105.998 14.803
201903 12.305 107.251 15.480
201906 12.709 108.070 15.867
201909 12.964 108.329 16.147
201912 12.746 108.420 15.862
202003 12.214 108.902 15.133
202006 11.929 108.767 14.798
202009 17.265 109.815 21.213
202012 18.144 109.897 22.276
202103 16.924 111.754 20.433
202106 16.665 114.631 19.615
202109 18.863 115.734 21.991
202112 19.428 117.630 22.285
202203 19.593 121.301 21.794
202206 19.500 125.017 21.046
202209 21.278 125.227 22.926
202212 19.151 125.222 20.635
202303 19.267 127.348 20.414
202306 18.930 128.729 19.841
202309 18.863 129.860 19.599
202312 18.733 129.419 19.530
202403 19.435 131.776 19.900
202406 19.882 132.554 20.238
202409 19.838 133.029 20.121
202412 21.578 133.157 21.865
202503 21.709 134.927 21.709

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quest Diagnostics  (FRA:QDI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Quest Diagnostics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Quest Diagnostics Headlines

No Headlines